As drug development becomes more complex, so do the demands for accurate, reproducible bioanalytical data to prove their safety and efficacy. Method validation ensures the reliability of ...

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Nvidia is expanding physical AI through new partnerships in lab robotics and ...

Biosero, announces the early-access release of new assistive AI capabilities integrated into Green Button Go®, an innovation that allows users to create, review, and troubleshoot automation workflows ...

Two researchers in white lab coats and goggles regard the robotic elements of a lab of the future enabled by artificial intelligence. Exscientia recently opened a laboratory in Oxfordshire, England, ...

René Lacerte, CEO, reported that "During Q2, we continued to build on the strong momentum of Q1 and delivered a meaningful beat on both core revenue and profitability. Our consistent and disciplined ...

This article first appeared on GuruFocus. Ginkgo Bioworks (NYSE:DNA) says a new AI collaboration with OpenAI is already paying off, cutting the cost of protein production in the lab by a meaningful ...

Drug discovery pipelines are notorious for being costly, slow, and failure-prone, leading to AI and machine learning becoming more commonplace to accelerate progress and improve outcomes. Currently, ...

Artificial intelligence (AI) in drug discovery is moving beyond the proof-of-concept stage. Advanced machine learning (ML) techniques are powering technologies that slash the time needed to value and ...